By utilizing LCM-MS, we found that the MUC5B promoter variant, the strongest risk factor for IPF development, predominantly impacts the proteomic profiles of nonfibrotic lung tissue. This evidence concerns the gene MUC5B and idiopathic pulmonary fibrosis.